.png)

.png)
The Mito2021 Conference will be the opportunity to once again bring together our entire communities
to discuss topics and questions that are relevant to all. This pandemic has been a difficult time for
many, and we have all had to learn to adjust to new ways of engagement. After two years the
Mitochondrial Innovation Initiative (MITO2i), MitoCanada and the Brain and Mind Institute at UOttawa,
in partnership, are pleased to virtually host the MITO2021 Conference and give our communities a sense
of belonging, opportunity to have their questions addressed and learn about developments in the field
of mitochondrial disease, research and medicine.
The conference will allow for patients to engage with researchers and clinicians, trainees to further
involve themselves in areas of mitochondrial medicine and research, create further awareness and
relevance for mitochondrial disease and dysfunction, inform on clinical diagnosis and explore new
treatments and therapies, provide a platform for patient voices to be heard and attract foundations and
industry that have an interest in this important cause.
We are excited for you all to join us for this online event and help us spread the word that mitochondria
matters to millions!
FRIDAY NOVEMBER 26
8:00am - 6:00pm EST
Opening Remarks and messaging videos,
Welcome and Introductions:
Professor Ana Andreazza, Departments of Pharmacology and Psychiatry, University of Toronto, Scientific Director, MITO2i
Professor Ruth Slack, Director of Brain and Mind Institute University of Ottawa
Kate Murray, CEO & President MitoCanada
Keynote Panel: – Mitochondria Biology & Therapies – Chair Professor Ana Andreazza
Q&A with Clinical Experts - Chair Kate Murray (CEO and president of MitoCanada Foundation)
Please submit your questions to our clinical experts by Monday, November 21st, to info@mito2i.ca.
Wellcome Centre for Mitochondrial Research (WCMR) Clinician Real-Time Training


An interactive training session with case discussion, video clips and investigation of results.
Lunch - Invitation to Open Rooms
Natural Heath Products Availability and Accessibility for patients with mitochondrial
disease - from research to patient registry to policy making - Chair Sonya Brijbassi, Associate Director Strategy & Partnerships MITO2i
Dana El Soufi El Sabbagh
PhD. Candidate, UofT
NHP Task Force Coordinator
Nicole Kish
Bachelor’s of Science
Patient Registry Coordinator
Aneesa Grewal
Law and Policy Student
Ammanie Abdul-Fatah
Health, Science, Technology and Policy Student
International State of Mitochondrial Disease Patient Registries
Leila Esmaeilisaraji
Health, Science, Technology and Policy Student
International State of Mitochondrial Disease Patient Registries
Keynote Panel #2 Mitochondria and Neurodegenerative conditions - Chair Professor Ruth Slack, University of Ottawa
Mitochondrial Collective Discussion Part 2 – continuing the discussion from Global Mitochondria Awareness Week with Mitochondria Organizations from around the globe.
Professor Kostas Tokatlidis is the Cathcart Chair for Biochemistry, Head of the Mitochondrial Biology Laboratory and scientific lead of the Mitochondria and Us network
Michael Johnson, PhD Innovation Leadership Fellow
The Innovation School, The Glasgow School of Art
Sonya Brijbassi, Associate Director Strategy & Partnerships MITO2i.
Official launch of 'Superheroes Like Me', a book by patient advocate and MITO2i community member Thomas C. Zachos.

Break (Invitation to Open Rooms)
Mitochondria Replacement Therapy – Addressing safety concerns
Professor Eric Shoubridge, Chair of the Department of Human Genetics at McGill University.
Chair - Kate Murray
Closing Remarks – MitoCanada/MITO2i/UOttawa
Join us after the closing remarks for a social time and networking with colleagues
Special Trainee Event - Training in mitochondria technologies
Chris Perry, Associate Professor
Faculty of Health, York University
Chair - Sonya Brijbassi